• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Uniqure Ord Shs (NQ: QURE )

    5.950 +2.170 (+57.41%)
    Streaming Delayed Price Updated: 9:31 AM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8,958,737
    Open 6.190
    Bid (Size) 5.930 (3)
    Ask (Size) 5.950 (1)
    Prev. Close 3.780
    Today's Range 5.790 - 6.440
    52wk Range 3.730 - 11.62
    Shares Outstanding 48,549,437
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire
    uniQure Announces Sale of Commercial Manufacturing Facility to Genezen
    From uniQure Inc.
    Via GlobeNewswire

    Performance

    YTD
    -14.14%
    -14.14%
    1 Month
    +10.59%
    +10.59%
    3 Month
    +14.42%
    +14.42%
    6 Month
    -12.50%
    -12.50%
    1 Year
    -48.48%
    -48.48%

    More News

    Read More
    uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire
    Recap: uniQure Q4 Earnings
    Via Benzinga
    Why Shares of uniQure Are Up Thursday
    Via The Motley Fool
    QURE Stock Earnings: uniQure Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
    From uniQure Inc.
    Via GlobeNewswire
    Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
    Via Investor's Business Daily
    Exposures Product Safety
    AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
    From uniQure Inc.
    Via GlobeNewswire
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire
    uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From uniQure Inc.
    Via GlobeNewswire
    uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
    From uniQure Inc.
    Via GlobeNewswire
    3 Micro-Cap Stocks That Could Be Moonshots
    Via InvestorPlace
    uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
    From uniQure Inc.
    Via GlobeNewswire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting
    From uniQure Inc.
    Via GlobeNewswire
    Gene Therapy Player UniQure To Lay Off 20% Of Workforce, Stop Parkinson's Study
    Via Benzinga
    uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs
    From uniQure Inc.
    Via GlobeNewswire
    uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From uniQure Inc.
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.